Items | Before intervention | Intervention period | Follow-up period | ||||
---|---|---|---|---|---|---|---|
Screening | Evaluatea | Weeks 1-12 | Evaluateb | Weeks 13-36 | Evaluatec | ||
Enrollment | × |  |  |  |  |  | |
Informed consent | × |  |  |  |  |  | |
Basic information | × |  |  |  |  |  | |
Inclusion and exclusion criteria | × |  |  |  |  |  | |
Randomization and allocation | × |  |  |  |  |  | |
Primary outcomes | MMSE | × | × |  | × |  | × |
Secondary outcomes | MoCA |  | × |  | × |  | × |
 | TAP |  | × |  | × |  |  |
 | WMS |  | × |  | × |  |  |
 | TMT |  | × |  | × |  |  |
 | Stroop |  | × |  | × |  |  |
 | MBI |  | × |  | × |  | × |
 | SF-36 |  | × |  | × |  | × |
 | FMA |  | × |  | × |  |  |
 | fMRI |  | × |  | × |  |  |
 | ERP |  | × |  | × |  |  |
Treatment recorded |  |  | × |  | × |  | |
Adverse events recorded |  |  | × |  | × |  | |
Rehabilitation expenses questionnaire |  |  | × |  | × | × |